Abstract
BMP-1/ tolloid like proteases collectively referred as BTPs are members of the astacin family of metalloproteases belonging to the metzincin clan. Four members of BTP are identified in humans; BMP-1, mTLD, mTLL1 and mTLL2. The BTPs are involved in several pathophysiological diseases including bone morphogenesis, fibrosis, tissue remodeling and tumor progression. BTPs are important regulators to activate several growth factors and helps to release anti-angiogenic fragments from parent proteins. Three dimensional structure of BTPs reveal the presence of a highly unusual disulphide bridge present within the cysteine-rich loop region in the active site. The activity of BTPs is controlled mainly by activators. The only endogenous inhibitor of mammalian BTPs is α2-macroglobulin. Several small molecular inhibitors of BTPs have been reported. Further studies will help to explore the full spectrum of activities of BTPs which will help in recognition of BTPs as new targets for future therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Muir A and Greenspan DS (2011) Metalloproteinases in Drosophila to humans that are central players in developmental processes. J BiolChem286:41905–41911
Sterchi EE, Stocker Wand Bond JS (2008) Meprins, membrane-bound and secreted astacin metalloproteinases. Mol Asp Med 29:309–328
Takahara K, Lyons GE, Greenspan DS (1994) Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues. J BiolChem 269:32572–32578
Urist MR (1965) Bone: formation by autoinduction. Science 150:893–899
Constam DB, Robertson EJ (1999) Regulation of bone morphogenetic protein activity by prodomains and proprotein convertases. J Cell Biol 144:139–149
Mac Sweeney A, Gil-Parrado S, Vinzenz D, Bernardi A, Hein A, Bodendorf U, Erbel P, Logel C, Gerhartz B (2008) Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases. J MolBiol 384:228–239
Wozney JM, Rosen V, Celeste AJ et al (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534
Vadon-Le Goff S, Hulmes DJS, Moali C (2015) BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol 44–46C:14–23
Wermter C, Howel M, Hintze V, Bombosch B, Aufenvenne K, Yiallouros I et al (2007) The protease domain of procollagen C proteinase (BMP1) lacks substrate selectivity, which isconferred by non-proteolytic domains. BiolChem 388:513–521
Garrigue-Antar L, Barker C, Kadler KE (2001) Identification of amino acid residues in bone morphogenetic protein-1 important for procollagen C-proteinase activity. J Biol Chem 276:26237–26242
Gaoxiang Ge and Neung-SeonSeo et al. (2004) Bone morphogenetic protein-1/Tolloid-related metalloproteinases process Osteoglycin and enhance its ability to regulate collagen Fibrillogenesis. J Biol Chem 279:41626–41633
Kessler E (2004) Procollagen C-endopeptidase. In: Barret AJ, Rawlings ND, Woessner JF (eds) Handbook of proteolytic enzymes. Elsevier Ltd, London, pp 609–617
King GN, King N, Hughes FJ (1998) Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo. J Periodontal Res 33:226–236
Gopalakrishnan B, Wang WM, Greenspan DS (2004) Biosynthetic processing of the pro- alpha1(V)pro-alpha2(V)Proalpha3(V) procollagen heterotrimer. J Biol Chem 279:30904–30912
Imamura Y, Steiglitz BM, Greenspan DS (1998) Bone morphogenetic protein-1 processes the NH2-terminal propeptide, and a furin-like proprotein convertase processes the COO terminal propeptide of pro-alpha1(V) collagen. J Biol Chem 273:27511–27517
Delolme F, Anastasi C, Alcaraz LB, Mendoza V, Vadon-Le Goff S, Talantikite M et al (2015) Proteolytic control of TGF-beta coreceptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics. Cell Mol Life Sci 72:1009–1027
Lee SB, Solow-Cordero DE, Kessler E, Takahara K, Greenspan DS (1997) Transforming growth factor-beta regulation of bone morphogenetic protein-1 procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 272:19059–19066
Tovar-Vidales T, Fitzgerald AM, Clark AF, Wordinger RJ (2013) Transforming growth factor-beta2 induces expression of biologically active bone morphogenetic protein-1 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 54:4741–4748
Ge G, Greenspan DS (2006) BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 175:111–120
Marques G, Musacchio M, Shimell MJ, Wunnenberg-Stapleton K, KWY C, O’Connor MB (1997) Production of a DPP activity gradient in the early drosophila embryo through the opposing actions of the SOG and TLD proteins. Cell 91:417–426
Piccolo S, Agius E, Lu B, Goodman S, Dale L, De Robertis EM (1997) Cleavage of chordin by xolloid metalloproteinase suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91:407–416
Kim B, Huang G, Ho WB, Greenspan DS (2011) Bone morpho- genetic protein-1 processes insulin-like growth factor- binding protein 3. J BiolChem 286:29014–29025
Ge G, Fernandez CA, Moses MA, Greenspan DS (2007) Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc Natl AcadSci U S A104:10010–10015
Odagiri H, Kadomatsu T, Endo M, Masuda T, Morioka MS, Fukuhara S et al (2014) The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin alpha5- beta1, p38 MAPK, and matrix metalloproteinases. Sci signal 7:ra7
Reid RR, Mogford JE, Butt R, deGiorgio-Miller A, Mustoe TA (2006) Inhibition of procollagen C-proteinase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair Regen 14:138–141
Wong VW, You F, Januszyk M, Gurtner GC, Kuang AA (2014) Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars. Ann PlastSurg 72:711–719
MalecazeF MD, Fournie P, Tricoire C, CassagneM MM et al (2014) Upregulation of bone morphogenetic protein-1/mammalian tolloid and procollagen C-proteinase enhancer-1 in corneal scarring. Invest Ophthalmol Vis Sci 55:6712–6721
Ogata I, Auster AS, Matsui A, Greenwel P, Geerts A, D'Amico T et al (1997) Up-regulation of type I procollagen Cproteinase enhancer protein messenger RNA in rats with CCl4-induced liver fibrosis. Hepatology 26:611–617
Beaumont J, Lopez B, Hermida N, Schroen B, San JG, Heymans S et al (2014) microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-beta1 up-regulation. ClinSci (Lond) 126:497–506
Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E et al (2011) COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 32:598–609
Asharani PV, Keupp K, Semler O, Wang W, Li Y, Thiele H et al (2012) Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 90:661–674
Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M, Temtamy S, Tenorio J et al (2012) Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in auto- somal recessive osteogenesis imperfecta. Hum Mutat 33:343–350
Valencia M, Caparros-Martin JA, Sirerol-Piquer MS, Garcia-Verdugo JM, Martinez-Glez V, Lapunzina P et al (2014) Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects. Am J Med Genet A 164A:1143–1150
Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO (2014) Extracellularmatrix signatures of humanmammary carcinoma identify novel metastasis promoters. elife 3:e01308
Torres S, Bartolome RA, Mendes M, Barderas R, Fernandez-Acenero MJ, Pelaez-Garcia A et al (2013) Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 19:6006–6019
Wu X, Liu T, Fang O, Leach LJ, Hu X, Luo Z (2014) miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1). Oncogene 33:1506–1514
Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CC (2011) The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. MolBiol Cell 22:3791–3800
Steiglitz BM, Keene DR and Greenspan DS (2002) PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modifica- tion from the previously described PCPE1. J BiolChem277:49820–49830
Yamaguchi Y (2014) Periostin in skin tissue and skin-related diseases. AllergolInt 63:161–170
Huang G, Zhang Y, Kim B, Ge G, Annis DS, Mosher DF et al (2009) Fibronectin binds and enhances the activity of bone morphogenetic protein 1. J BiolChem 284:25879–25888
Inomata H, Haraguchi T, Sasai Y (2008) Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation. Cell 134:854–865
Leung MK, Fessler LI, Greenberg DB andFessler JH (1979) Separate amino and carboxyl procollagen peptidases in chick embryo tendon.J BiolChem254:224–232
Kessler E, Adar R, Goldberg B andNiece R (1986) Partial purification and characterization of a procollagen C-proteinase from the culture medium of mouse fibroblasts.CollRelat Res6:249–266
Allan GA, Gedge JI, Nedderman AN, Roffey SJ, Small HF, Webster R (2006) Pharmacokinetics and metabolism of UK-383,367 in rats and dogs: a rationale for long-lived plasma radioactivity. Xenobiotica 36:399–418
Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW (2003) Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates. Bioorg Med Chem Lett 13:2381–2384
Bijakowski C, Vadon-Le Goff S, Delolme F, Bourhis JM, Lécorché P, Ruggiero F, Becker-Pauly C, Yiallouros I, Stöcker W, Dive V, Hulmes DJS, Moali C (2012) Sizzled is unique among secreted frizzled-related proteins for its ability to specifically inhibit bone morphogenetic protein-1 (BMP-1)/tolloid-like proteinases. J BiolChem 287:33581–33593
Zhang Y, Ge G, Greenspan DS (2006) Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin. J BiolChem 281:39096–39104
Hansch C, Kurup A, Garg R, Gao H (2001) Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. Chem Rev 101:619–672
Khazaei A, Sarmasti N, Seyf JY,Rostami Z, Zolfigol MA (2015) QSAR study of the non-peptidic inhibitors of procollagen C-proteinase based on multiple linear regression, principle component regression, and Partial Least Square Arabian J Chem
Acknowledgement
The authors sincerely thank Dr. Indrani Sarkar of Narula Institute of Technology for her useful suggestions in preparation of the chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Chakraborty, S., Chaudhuri, A., Bera, A.K. (2017). Role of BMP1/Tolloid like Proteases in Bone Morphogenesis and Tissue Remodeling. In: Chakraborti, S., Dhalla, N. (eds) Proteases in Physiology and Pathology. Springer, Singapore. https://doi.org/10.1007/978-981-10-2513-6_4
Download citation
DOI: https://doi.org/10.1007/978-981-10-2513-6_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-2512-9
Online ISBN: 978-981-10-2513-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)